Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

NCT07093931 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

468

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: lobaplatin
DRUG: carboplatin
DRUG: Docetaxel or albumin paclitaxel
DRUG: Trastuzumab
DRUG: pertuzumab

Sponsor

Shandong Cancer Hospital and Institute

Collaborators

[object Object]